Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Afaf E G Osman

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 4, 2019
The Impact of the Fecal Microbiome on Cancer ImmunotherapyAfaf E G Osman, Jason J Luke
Blood Reviews|March 28, 2021
Chronic Myeloid Leukemia: Modern therapies, current challenges and future directionsAfaf E G Osman, Michael W Deininger
Leukemia Research|July 8, 2023
Germline predisposition to clonal hematopoiesisJie Liu, Afaf E G Osman, Kelly Bolton, et al.
Current Hematologic Malignancy Reports|September 28, 2018
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and ControversiesImo J Akpan, Afaf E G Osman, Michael W Drazer, et al.
Clinical Neurology and Neurosurgery|December 6, 2021
Solitary manifestations of primary B-lymphoblastic lymphoma of the spine: Systematic literature review with case illustrationDavide Marco Croci, Nicholas T Gamboa, Afaf E G Osman, et al.
JACC. Cardiooncology|October 10, 2022
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular ToxicityBrian Yu, Afaf E G Osman, Nikola Sladojevic, et al.
Journal of Translational Genetics and Genomics|August 9, 2021
Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates <i>CXCR4</i> in inherited riskJulie E Feusier, Michael J Madsen, Brian J Avery, et al.
Journal of Oncology Practice|November 14, 2018
Treatment of Acute Promyelocytic Leukemia in AdultsAfaf E G Osman, Jennifer Anderson, Jane E Churpek, et al.
JCO Precision Oncology|June 20, 2025
Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni SyndromeJennie Vagher, Anna Zakas, Lauren Donovan, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 4, 2019
The Impact of the Fecal Microbiome on Cancer ImmunotherapyAfaf E G Osman, Jason J Luke
Blood Reviews|March 28, 2021
Chronic Myeloid Leukemia: Modern therapies, current challenges and future directionsAfaf E G Osman, Michael W Deininger
Leukemia Research|July 8, 2023
Germline predisposition to clonal hematopoiesisJie Liu, Afaf E G Osman, Kelly Bolton, et al.
Current Hematologic Malignancy Reports|September 28, 2018
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and ControversiesImo J Akpan, Afaf E G Osman, Michael W Drazer, et al.
Clinical Neurology and Neurosurgery|December 6, 2021
Solitary manifestations of primary B-lymphoblastic lymphoma of the spine: Systematic literature review with case illustrationDavide Marco Croci, Nicholas T Gamboa, Afaf E G Osman, et al.
JACC. Cardiooncology|October 10, 2022
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular ToxicityBrian Yu, Afaf E G Osman, Nikola Sladojevic, et al.
Journal of Translational Genetics and Genomics|August 9, 2021
Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates <i>CXCR4</i> in inherited riskJulie E Feusier, Michael J Madsen, Brian J Avery, et al.
Journal of Oncology Practice|November 14, 2018
Treatment of Acute Promyelocytic Leukemia in AdultsAfaf E G Osman, Jennifer Anderson, Jane E Churpek, et al.
JCO Precision Oncology|June 20, 2025
Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni SyndromeJennie Vagher, Anna Zakas, Lauren Donovan, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Pageof 2